Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-08T15:21:57.903Z Has data issue: false hasContentIssue false

Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA

Published online by Cambridge University Press:  24 August 2016

YAN DING
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
WENYUE XU
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
TAOLI ZHOU
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
TAIPING LIU
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
HONG ZHENG
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
YONG FU*
Affiliation:
Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China
*
*Corresponding author: Department of Pathogenic Biology, Third Military Medical University, 30 Gaotanyan Zhengjie, Shapingba District, Chongqing 400038, People's Republic of China. E-mail: vincentfeu.tmmu@gmail.com

Summary

Malaria remains one of the most devastating diseases. Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection resulting in high mortality and morbidity worldwide. Analysis of precise mechanisms of CM in humans is difficult for ethical reasons and animal models of CM have been employed to study malaria pathogenesis. Here, we describe a new experimental cerebral malaria (ECM) model with Plasmodium berghei ANKA infection in KunMing (KM) mice. KM mice developed ECM after blood-stage or sporozoites infection, and the development of ECM in KM mice has a dose-dependent relationship with sporozoites inoculums. Histopathological findings revealed important features associated with ECM, including accumulation of mononuclear cells and red blood cells in brain microvascular, and brain parenchymal haemorrhages. Blood–brain barrier (BBB) examination showed that BBB disruption was present in infected KM mice when displaying clinical signs of CM. In vivo bioluminescent imaging experiment indicated that parasitized red blood cells accumulated in most vital organs including heart, lung, spleen, kidney, liver and brain. The levels of inflammatory cytokines interferon-gamma, tumour necrosis factor-alpha, interleukin (IL)-17, IL-12, IL-6 and IL-10 were all remarkably increased in KM mice infected with P. berghei ANKA. This study indicates that P. berghei ANKA infection in KM mice can be used as ECM model to extend further research on genetic, pharmacological and vaccine studies of CM.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2016 
Figure 0

Fig. 1. Course of PbA and PbNK infection in KM mice. KM mice were  injected i.p. with 106 PbA or PbNK parasites. Parasitaemia (A), survival (B), cumulative ECM incidence (C), body weight (D) and red blood cells (E) were recorded at selected time point. n = 25 mice per group. Parasitaemia, body weight and red blood cells were evaluated by non-parametric Mann–Whitney U test at 6 dpi and Log-rank test was used for survival. **P < 0·01; ****P < 0·0001. The data are representatives of three independent experiments.

Figure 1

Fig. 2. Comparison of ECM in KM mice infected with different doses of sporozoites. (A) ECM incidence were evaluated in KM mice infected with different doses of sporozoites (1 × 103, 5 × 103, 1 × 104, 5 × 104). Parasitaemia (B) and survival (C) were assessed during the course of infection for mice infected with sporozoites or 106 pRBCs. n = 25 mice per group. The data are representatives of two independent experiments. **P < 0·01; ns, non-significant, non-parametric Mann–Whitney U test. NECM, no experimental cerebral malaria; spz, sporozoites.

Figure 2

Fig. 3. Severe alterations in the brain of KM mice after PbA infection. BBB disruption was assessed in PbA-infected mice, PbNK-infected KM mice or non-infected (NI) mice by Evans blue at 6 dpi (A, B). Histopathological evaluation of the brain was assessed by H&E staining at same time (C). n = 5 mice per group. **P < 0·01; ns, non-significant, Kruskal–Wallis test. Arrowhead show brain microvascular congestion and arrow show brain haemorrhage in PbA-infected mice. Bar = 100 µm.

Figure 3

Fig. 4. Parasite burden in PbA–luc-infected KM mice. All KM mice were infected with 106 PbA–luc pRBCs. On 6 dpi, when mice were exhibiting typical signs of ECM, in vivo bioluminescence imaging of pRBCs accumulation in the whole body (A) and dissected organs (B) of PbA–luc-infected KM mice was performed after luciferin injection and quantification of parasite burden in various organs (C) was determined after a second luciferin injection followed by intracardiac perfusion. Quantification of brain CD8β mRNA expression (D) was assessed by qRT–PCR. ns, non-significant, non-parametric Mann–Whitney U test. Data are representatives of two independent experiments.

Figure 4

Fig. 5. Cytokines production of PbA-infected and PbNK-infected KM mice. KM mice were infected with 106 PbA or PbNK pRBCs. Blood samples were collected from these infected KM mice at 2, 4, 6 dpi. The levels of pro-inflammatory cytokines IFN-γ, TNF-α, IL-17, IL-12, IL-6 and anti-inflammatory cytokine IL-10 in plasma were determined by flow cytometry using the CBA mouse inflammation kit. *P < 0·05; **P < 0·01; ***P < 0·001, non-parametric Mann–Whitney U test, all are PbA vs PbNK. Data are representatives of three independent experiments.